share_log

新銳醫藥:須予披露交易 -合作協議及增加對目標公司的注資之補充公告

NEW RAY MEDIC: SUPPLEMENTAL ANNOUNCEMENTDISCLOSEABLE TRANSACTION -COOPERATION AGREEMENT AND INCREASE IN CAPITALCONTRIBUTION OF THE TARGET COMPANY

HKEX ·  Jul 9 20:48

Summary by Futu AI

新銳醫藥國際控股有限公司(新锐医药)於2024年7月9日宣布,其目標公司在中國浙江省嵊州的健康食品產業園項目,已成功通過公開競標獲得土地使用權,最終標價為人民幣14.7百萬元。新銳醫藥持有目標公司39%的股權。產業園將提供生產、物流、研發等一系列複合功能,並預計於2024年第三季度開始對外銷售及租賃。目標公司將負責產業園的營運及管理,並根據市場需求決定設施及樓宇的最終用途。
新銳醫藥國際控股有限公司(新锐医药)於2024年7月9日宣布,其目標公司在中國浙江省嵊州的健康食品產業園項目,已成功通過公開競標獲得土地使用權,最終標價為人民幣14.7百萬元。新銳醫藥持有目標公司39%的股權。產業園將提供生產、物流、研發等一系列複合功能,並預計於2024年第三季度開始對外銷售及租賃。目標公司將負責產業園的營運及管理,並根據市場需求決定設施及樓宇的最終用途。
New Ray Medic International Holdings Limited (New Ray Medicine) announced on July 9, 2024 that its target company's health food industry park project in Shengzhou, Zhejiang Province, China has successfully obtained the land use right through public bidding with a final bid price of RMB 14.7 million. New Ray Medic holds 39% of the target company's shares. The industrial park will provide a range of complex functions including production, logistics, and R&D. It is expected to start selling and leasing to the public in the third quarter of 2024. The target company will be responsible for the operation and management of the industrial park, and will determine the final use of facilities and buildings according to market demand.
New Ray Medic International Holdings Limited (New Ray Medicine) announced on July 9, 2024 that its target company's health food industry park project in Shengzhou, Zhejiang Province, China has successfully obtained the land use right through public bidding with a final bid price of RMB 14.7 million. New Ray Medic holds 39% of the target company's shares. The industrial park will provide a range of complex functions including production, logistics, and R&D. It is expected to start selling and leasing to the public in the third quarter of 2024. The target company will be responsible for the operation and management of the industrial park, and will determine the final use of facilities and buildings according to market demand.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.